Systemic deuteration of SCID mice using the water‐isotopologue deuterium oxide (D 2 O) inhibits tumor growth in an orthotopic bioluminescent model of human pancreatic ductal adenocarcinoma
Molecular Carcinogenesis · 2023-05 · 62 (5) · 598-612
DOI: 10.1002/mc.23509 ↗At a glance
Journal article in Molecular Carcinogenesis, published online on 2023-02-02. Written by Jana Jandova and 3 co-authors. Institution: Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy & UA Cancer Center, The University of Arizona, Tucson, Arizona, USA. Major MEDLINE topics: Drinking Water, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Cited 6 times so far (Crossref); 69 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NCI NIH HHS, NCRR NIH HHS, NIH HHS.
Abstract (original language)
Since its initial discovery as a natural isotopologue of dihydrogen oxide ( 1 H 2 O), extensive research has focused on the biophysical, biochemical, and pharmacological effects of deuterated water ( 2 H 2 O [D 2 O, also referred to as “heavy water”]). Using a panel of cultured human pancreatic ductal adenocarcinoma (PDAC) cells we have profiled (i) D 2 O‐induced phenotypic antiproliferative and apoptogenic effects, (ii) redox‐ and proteotoxicity‐directed stress response gene expression, and (iii) phosphoprotein‐signaling related to endoplasmic reticulum (ER) and MAP‐kinase stress response pathways. Differential array analysis revealed early modulation of stress response gene expression in both BxPC‐3 and PANC‐1 PDAC cells elicited by D 2 O (90%; ≤6 h; upregulated: HMOX1 , NOS2 , CYP2E1 , CRYAB , DDIT3 , NFKBIA , PTGS1 , SOD2 , PTGS2 ; downregulated: RUNX1 , MYC , HSPA8 , HSPA1A ) confirmed by independent RT‐qPCR analysis. Immunoblot‐analysis revealed rapid (≤6 h) onset of D 2 O‐induced MAP‐kinase signaling (p‐JNK, p‐p38) together with ER stress response upregulation (p‐eIF2α, ATF4, XBP1s, DDIT3/CHOP). Next, we tested the chemotherapeutic efficacy of D 2 O‐based drinking water supplementation in an orthotopic PDAC model employing firefly luciferase‐expressing BxPC‐3‐FLuc cells in SCID mice. First, feasibility and time course of systemic deuteration (30% D 2 O in drinking water; 21 days) were established using time‐resolved whole‐body proton magnetic resonance imaging and isotope‐ratio mass spectrometry‐based plasma (D/H)‐analysis. D 2 O‐supplementation suppressed tumor growth by almost 80% with downregulated expression of PCNA, MYC, RUNX1, and HSP70 while increasing tumor levels of DDIT3/CHOP, HO‐1, and p‐eIF2α. Taken together, these data demonstrate for the first time that pharmacological induction of systemic deuteration significantly reduces orthotopic tumor burden in a murine PDAC xenograft model.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy & UA Cancer Center, The University of Arizona, Tucson, Arizona, USA.
- Department of Medical Imaging, The University of Arizona, Tucson, Arizona, USA.
- Department of Geosciences, The University of Arizona, Tucson, Arizona, USA.
Funding
- NCI NIH HHS
- NCRR NIH HHS
- NIH HHS
- NIEHS NIH HHS
- National Institutes of Health
Cite
APA
Jandova, J., Galons, J. P., Dettman, D. L., & Wondrak, G. T. (2023). Systemic deuteration of SCID mice using the water‐isotopologue deuterium oxide (D 2 O) inhibits tumor growth in an orthotopic bioluminescent model of human pancreatic ductal adenocarcinoma. Molecular Carcinogenesis, 62(5), 598-612. https://doi.org/10.1002/mc.23509
Vancouver
Jandova J, Galons JP, Dettman DL, Wondrak GT. Systemic deuteration of SCID mice using the water‐isotopologue deuterium oxide (D 2 O) inhibits tumor growth in an orthotopic bioluminescent model of human pancreatic ductal adenocarcinoma. Molecular Carcinogenesis. 2023;62(5):598-612. doi:10.1002/mc.23509
BibTeX
@article{Jandova2023,
author = {Jandova, Jana and Galons, Jean-Philippe and Dettman, David L and Wondrak, Georg T},
title = {Systemic deuteration of SCID mice using the water‐isotopologue deuterium oxide (D 2 O) inhibits tumor growth in an orthotopic bioluminescent model of human pancreatic ductal adenocarcinoma},
journal = {Molecular Carcinogenesis},
year = {2023},
volume = {62},
number = {5},
pages = {598--612},
doi = {10.1002/mc.23509}
}
EUVIMED